Henry Schein, a global provider of health care products and services to office-based dental and medical practitioners, announced the acquisition of Regional Health Care Group (RHCG), a medical products distribution company serving public- and private-sector customers in Australia and New Zealand.
Since 1998, Henry Schein has served the Australian and New Zealand dental market, providing dental products, equipment, and services to dental professionals. The addition of RHCG expands Henry Schein’s offering to medical practitioners in the region.
Henry Schein acquired RHCG, which had sales for the 12 months ended 30 Jun 2022, of US$42m, from Maurie and Bernard Stang, who wholly owned the company and retain a minority interest in Henry Schein’s Australian and New Zealand dental business. Henry Schein expects the transaction to be neutral to 2023 diluted earnings per share when excluding amortisation expenses and accretive thereafter. Financial terms were not disclosed.
Headquartered in Sydney, Australia, with an office in Auckland, New Zealand, RHCG offers a range of consumables, equipment, and pharmaceuticals — including many on an exclusive or semi-exclusive basis —to public- and private-sector customers. The day-to-day operations of RHCG are led by general manager Stephen Doorey, who will continue to manage the business under the RHCG brand. Doorey will report to Mike Covey, vice-president and managing director of Henry Schein’s business in Australia and New Zealand.
“We are pleased to integrate RHCG with Henry Schein, a company that provides customers with the solutions they need to deliver quality care to their patients,” said Stang.
